TABLE OF CONTENTS
Detailed Table of Contents
Chapter 1 — Executive Summary
1.1Market Overview
1.22025 Market Size and 2035 Forecast
1.3Largest and Fastest-Growing Segments
1.4Key Country and Regional Highlights
1.5Competitive Positioning
1.6Strategic Recommendations
Chapter 2 — Research Scope and Methodology
2.1Market Definitions and Boundaries
2.2Base Year and Forecast Period
2.3Primary Research
2.4Secondary Research
2.5Bottom-Up Market Estimation
2.6Top-Down Market Estimation
2.7Data Triangulation
2.8Forecast Assumptions and Limitations
Chapter 3 — Market Dynamics
3.1Growth Drivers
3.2Market Restraints
3.3Growth Opportunities
3.4Industry Challenges
3.5Emerging Trends
3.6Porter’s Five Forces
3.7Value Chain and Pricing Analysis
Chapter 4 — Technology, Regulatory and Commercial Landscape
4.1Technology Evolution
4.2Product Innovation and Pipeline
4.3Regulatory Approvals and Compliance
4.4Clinical and Performance Evidence
4.5Reimbursement and Payer Access
4.6Distribution and Procurement
4.7Digital Integration and Interoperability
Chapter 5 — Market Size and Forecast, 2025–2035
5.1Market Revenue, 2025–2035
5.2Year-on-Year Growth and CAGR
5.3Revenue by Segment
5.4Largest Segment and Growth Rationale
5.5Fastest-Growing Segment and Growth Rationale
5.6Forecast Scenarios and Sensitivities
Chapter 6 — Market Analysis, by Component
6.1Overview and Market Definition
6.2Revenue and Forecast, 2025–2035
6.3Subsegment Analysis
6.3.1Sensors: Disposable and Implantable
6.3.2Transmitters
6.3.3Receivers and Readers
6.3.4Software and Accessories
6.4Largest Subsegment: Share and Drivers
6.5Fastest-Growing Subsegment: CAGR and Drivers
6.6Competitive and Commercial Implications
Chapter 7 — Market Analysis, by Technology
7.1Overview and Market Definition
7.2Revenue and Forecast, 2025–2035
7.3Subsegment Analysis
7.3.1Real-Time CGM
7.3.2Intermittently Scanned CGM
7.3.3Implantable CGM
7.4Largest Subsegment: Share and Drivers
7.5Fastest-Growing Subsegment: CAGR and Drivers
7.6Competitive and Commercial Implications
Chapter 8 — Market Analysis, by Patient Type
8.1Overview and Market Definition
8.2Revenue and Forecast, 2025–2035
8.3Subsegment Analysis
8.3.1Type 1 Diabetes
8.3.2Type 2 Diabetes: Insulin-Treated
8.3.3Type 2 Diabetes: Non-Insulin-Treated
8.3.4Other Patient Groups
8.4Largest Subsegment: Share and Drivers
8.5Fastest-Growing Subsegment: CAGR and Drivers
8.6Competitive and Commercial Implications
Chapter 9 — Market Analysis, by End User
9.1Overview and Market Definition
9.2Revenue and Forecast, 2025–2035
9.3Subsegment Analysis
9.3.1Homecare
9.3.2Hospitals and Clinics
9.3.3Diabetes Centers
9.4Largest Subsegment: Share and Drivers
9.5Fastest-Growing Subsegment: CAGR and Drivers
9.6Competitive and Commercial Implications
Chapter 10 — Market Analysis, by Distribution Channel
10.1Overview and Market Definition
10.2Revenue and Forecast, 2025–2035
10.3Subsegment Analysis
10.3.1Hospital Pharmacies
10.3.2Retail Pharmacies
10.3.3Online and Direct-to-Consumer
10.4Largest Subsegment: Share and Drivers
10.5Fastest-Growing Subsegment: CAGR and Drivers
10.6Competitive and Commercial Implications
Chapter 11 — Country Analysis
11.1National Market Overview
11.2National Revenue and Forecast, 2025–2035
11.3Subnational Market and Access Analysis
11.3.1Northeast
11.3.2Midwest
11.3.3South
11.3.4West
11.3.5Medicare and Medicaid coverage variation
11.4Regulatory and Reimbursement Framework
11.5Urban–Rural Access and Adoption Differences
11.6Healthcare Infrastructure and Distribution
11.7National Competitive Dynamics
Chapter 12 — CGM versus SMBG Substitution and Revenue Crossover
12.1CGM and SMBG Revenue Scope and Definitions
12.22025 Manufacturer-Revenue Baseline
12.3CGM Revenue Forecast, 2025–2035
12.4Conventional SMBG Revenue Forecast, 2025–2035
12.5Crossover Year: Base, Upside and Downside Scenarios
12.6User Adoption versus Revenue Crossover
12.7Sensitivity to Coverage, Prices and Sensor Utilization
Chapter 13 — Competitive Landscape
13.1Competitive Structure
13.2Market Share and Concentration
13.3Product and Technology Benchmarking
13.4Pricing and Distribution Benchmarking
13.5Mergers and Acquisitions
13.6Partnerships and Collaborations
13.7New Product Launches
13.8Geographic Expansion
Chapter 14 — Company Profiles
14.1Abbott
14.1.1Company Overview
14.1.2Relevant Product and Service Portfolio
14.1.3Financial Performance (Where Disclosed)
14.1.4Geographic Presence
14.1.5Recent Strategic Developments
14.1.6SWOT and Competitive Positioning
14.2Dexcom
14.2.1Company Overview
14.2.2Relevant Product and Service Portfolio
14.2.3Financial Performance (Where Disclosed)
14.2.4Geographic Presence
14.2.5Recent Strategic Developments
14.2.6SWOT and Competitive Positioning
14.3Medtronic
14.3.1Company Overview
14.3.2Relevant Product and Service Portfolio
14.3.3Financial Performance (Where Disclosed)
14.3.4Geographic Presence
14.3.5Recent Strategic Developments
14.3.6SWOT and Competitive Positioning
14.4Senseonics
14.4.1Company Overview
14.4.2Relevant Product and Service Portfolio
14.4.3Financial Performance (Where Disclosed)
14.4.4Geographic Presence
14.4.5Recent Strategic Developments
14.4.6SWOT and Competitive Positioning
14.5Ascensia Diabetes Care
14.5.1Company Overview
14.5.2Relevant Product and Service Portfolio
14.5.3Financial Performance (Where Disclosed)
14.5.4Geographic Presence
14.5.5Recent Strategic Developments
14.5.6SWOT and Competitive Positioning
14.6Roche Diabetes Care
14.6.1Company Overview
14.6.2Relevant Product and Service Portfolio
14.6.3Financial Performance (Where Disclosed)
14.6.4Geographic Presence
14.6.5Recent Strategic Developments
14.6.6SWOT and Competitive Positioning
14.7i-SENS
14.7.1Company Overview
14.7.2Relevant Product and Service Portfolio
14.7.3Financial Performance (Where Disclosed)
14.7.4Geographic Presence
14.7.5Recent Strategic Developments
14.7.6SWOT and Competitive Positioning
14.8Medtrum
14.8.1Company Overview
14.8.2Relevant Product and Service Portfolio
14.8.3Financial Performance (Where Disclosed)
14.8.4Geographic Presence
14.8.5Recent Strategic Developments
14.8.6SWOT and Competitive Positioning
14.9Sinocare
14.9.1Company Overview
14.9.2Relevant Product and Service Portfolio
14.9.3Financial Performance (Where Disclosed)
14.9.4Geographic Presence
14.9.5Recent Strategic Developments
14.9.6SWOT and Competitive Positioning
14.10MicroTech Medical
14.10.1Company Overview
14.10.2Relevant Product and Service Portfolio
14.10.3Financial Performance (Where Disclosed)
14.10.4Geographic Presence
14.10.5Recent Strategic Developments
14.10.6SWOT and Competitive Positioning
Chapter 15 — Appendix
15.1Market Definitions and Acronyms
15.2Currency and Exchange Rate Assumptions
15.3Forecast Modeling Notes
15.4Source and Data Limitations
15.5Research Disclaimer